Dmytro S. Androsov
Research Subjects
Dmytro S. Androsov has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anna V. Khmel
Specialized Mammological Center, Kyiv, Ukraine
2 shared publications - Sergii V. Konovalenko
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
2 shared publications - Анастасія С. Лунько
Odesa National Medical University, Odesa, Ukraine
2 shared publications - A.D. Neborets
National Cancer Institute, Kyiv, Ukraine
1 shared publication - Hryhorii V. Chaika
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
1 shared publication - Tetiana A. Lunko
Odesa National Medical University, Odesa, Ukraine
1 shared publication
Latest Publications
- Open Access
- 28 February 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (1) , 28-34
Histological landmarks for choosing a therapeutic route in patients with overlap syndrome of genital endometriosis and benign breast disease
Background. Genital endometriosis (GE) remains a very common disease, occurring in 0.5–5 % of fertile women and in 25–40 % of infertile women. Benign breast diseases (BBD) are common throughout life, from early reproductive age to the postmenopausal period, making them a potential health problem for a large number of women. The histological characteristics of endometrial and breast tissues in patients suffering from the overlap syndrome of GE and BBD are of interest, since this condition carries an increased risk of endometrial, ovarian and breast cancer. The purpose was to study and identify the most characteristic features of endometrioid tissue and ductal hyperplasia tissue of the breast in women with overlap syndrome of GE and BBD using light microscopy. Materials and methods. Histological preparations of endometrioid foci and breast hyperplasia tissues of 148 women with overlap syndrome of GE and BBD were studied. The material was obtained by the method of fine-needle aspiration puncture biopsy, which was performed under ultrasound control. Cytological analysis and microphotography were performed using an Olympus CX23 microscope with different magnifications (×40, ×100 (immersion)). Results. The study showed that in the selected cohort of patients with overlap syndrome of GE and BBD, most histological samples showed proliferative activity of mesothelial cells. At the same time, morphological signs of atypia of cellular elements of atypical ductal hyperplasia were observed in 47.3 % of histological samples of breast tissue. Cells with signs of malignant transformation were not found in any of the provided breast tissue samples. It is important to note that in 15 % of patients, histological signs of malignancy were found in endometrial samples, which led to their immediate referral to a gynecological oncologist for surgical intervention and the necessary adjuvant therapy. Conclusions. In the prognosis of the clinical course of GE and BBD overlap syndrome, histological confirmation of the diagnosis and detection of signs of atypia in biopsy samples play a key role. The finding of atypical cells requires clinical consultation with the participation of a gynecologist, a mammologist and a gynecological oncologist, during which a decision is made regarding surgical intervention and the necessary pharmacotherapy.
- 28 February 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (1) , 28-34
Open AccessHistological landmarks for choosing a therapeutic route in patients with overlap syndrome of genital endometriosis and benign breast disease
Background. Genital endometriosis (GE) remains a very common disease, occurring in 0.5–5 % of fertile women and in 25–40 % of infertile women. Benign breast diseases (BBD) are common throughout life, from early reproductive age to the postmenopausal period, making them a potential health problem for a large number of women. The histological characteristics of endometrial and breast tissues in patients suffering from the overlap syndrome of GE and BBD are of interest, since this condition carries an increased risk of endometrial, ovarian and breast cancer. The purpose was to study and identify the most characteristic features of endometrioid tissue and ductal hyperplasia tissue of the breast in women with overlap syndrome of GE and BBD using light microscopy. Materials and methods. Histological preparations of endometrioid foci and breast hyperplasia tissues of 148 women with overlap syndrome of GE and BBD were studied. The material was obtained by the method of fine-needle aspiration puncture biopsy, which was performed under ultrasound control. Cytological analysis and microphotography were performed using an Olympus CX23 microscope with different magnifications (×40, ×100 (immersion)). Results. The study showed that in the selected cohort of patients with overlap syndrome of GE and BBD, most histological samples showed proliferative activity of mesothelial cells. At the same time, morphological signs of atypia of cellular elements of atypical ductal hyperplasia were observed in 47.3 % of histological samples of breast tissue. Cells with signs of malignant transformation were not found in any of the provided breast tissue samples. It is important to note that in 15 % of patients, histological signs of malignancy were found in endometrial samples, which led to their immediate referral to a gynecological oncologist for surgical intervention and the necessary adjuvant therapy. Conclusions. In the prognosis of the clinical course of GE and BBD overlap syndrome, histological confirmation of the diagnosis and detection of signs of atypia in biopsy samples play a key role. The finding of atypical cells requires clinical consultation with the participation of a gynecologist, a mammologist and a gynecological oncologist, during which a decision is made regarding surgical intervention and the necessary pharmacotherapy.
- Open Access
- 25 September 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Ukrainian educational and scientific medical space
- No. 1,p. 67-75
ETIOPATHOGENETIC JUSTIFICATION OF ENDOMETRIOSIS IMMUNOTHERAPY
Introduction. Genital endometriosis (GE) remains a fairly common disease, occurring in 0.5-5% of fertile women and in 25-40% of infertile women. In modern studies, the ability of endometrioid foci to actively resist immune surveillance, which causes changes in the behavior of regulatory cells: T-lymphocytes and macrophages, attracts attention. Aim. Using data from modern literary sources, to study the role of the immunological component in the etiology and pathogenesis of endometriosis and to outline the prospects for immunotherapeutic approaches to solving the problem. Materials and methods. The search and selection of publications, systematic reviews and current recommendations was carried out using the PubMed and Google Scholar databases. Abstracts of publications were studied and articles that did not meet the study criteria were excluded. The full texts of the selected articles were examined for compliance with the study criteria. Results. Ectopic endometrial cells, creating a new microenvironment around themselves and launching protective mechanisms against attacks by lymphocytes and macrophages, demonstrate to us how living microstructures are able to adapt and survive in unusual, even extreme, conditions. In connection with the key role of the immune system in the pathogenesis of GE established in studies, the pathogenetic significance of immunotropic drugs in the complex treatment of this disease is gaining increasing importance. An important condition for the successful use of immunocorrectors is their effect not only on the systemic components of the immune system, but also on local factors that determine the formation and development of endometrioid foci. Conclusions. It has been established that the immunological component plays a key role in the etiology and pathogenesis of endometriosis, which is confirmed by the data of modern scientific publications. The immunological direction in the treatment of endometriosis is predicted to undergo intensive development. Surgical treatment of endometriosis and restoration of immune homeostasis of the involved organs are necessary components of the comprehensive management of this category of patients.
- 25 September 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Ukrainian educational and scientific medical space
- No. 1,p. 67-75
Open AccessETIOPATHOGENETIC JUSTIFICATION OF ENDOMETRIOSIS IMMUNOTHERAPY
Introduction. Genital endometriosis (GE) remains a fairly common disease, occurring in 0.5-5% of fertile women and in 25-40% of infertile women. In modern studies, the ability of endometrioid foci to actively resist immune surveillance, which causes changes in the behavior of regulatory cells: T-lymphocytes and macrophages, attracts attention. Aim. Using data from modern literary sources, to study the role of the immunological component in the etiology and pathogenesis of endometriosis and to outline the prospects for immunotherapeutic approaches to solving the problem. Materials and methods. The search and selection of publications, systematic reviews and current recommendations was carried out using the PubMed and Google Scholar databases. Abstracts of publications were studied and articles that did not meet the study criteria were excluded. The full texts of the selected articles were examined for compliance with the study criteria. Results. Ectopic endometrial cells, creating a new microenvironment around themselves and launching protective mechanisms against attacks by lymphocytes and macrophages, demonstrate to us how living microstructures are able to adapt and survive in unusual, even extreme, conditions. In connection with the key role of the immune system in the pathogenesis of GE established in studies, the pathogenetic significance of immunotropic drugs in the complex treatment of this disease is gaining increasing importance. An important condition for the successful use of immunocorrectors is their effect not only on the systemic components of the immune system, but also on local factors that determine the formation and development of endometrioid foci. Conclusions. It has been established that the immunological component plays a key role in the etiology and pathogenesis of endometriosis, which is confirmed by the data of modern scientific publications. The immunological direction in the treatment of endometriosis is predicted to undergo intensive development. Surgical treatment of endometriosis and restoration of immune homeostasis of the involved organs are necessary components of the comprehensive management of this category of patients.